Bayer Aktiengesellschaft

Bayer Intellectual Property Gmbh

Aicuris Gmbh + Co. Kg.

Bayer Pharma Aktiengesellschaft

Bayer Healthcare Aktiengesellschaft

Bayer Schering Pharma Ag

Bayeraktiengesellschaft

Aicuris Anti-Infective Cures Gmbh

Aic246 Ag & Co. Kg

Aicuris Gmbh & Co. Hk

Elanco Animal Health Gmbh

Aicuris Gmbh & Co. Kg

Rudolf Schohe-Loop

Bodo Junge

Johannes-Peter Stasch

Andreas Turberg

Thomas Glaser

Hans-Georg Heine

Henning Sommermeyer

Bernard Schmidt

Heinrich Meier

Klaus Urbahns

Reilinde Wittka

Joachim Schuhmacher

Kerstin Henninger

Jean-Marie-Viktor De Vry

Wolfgang Dompert

Dieter Lang

Zhan Gao

Wolfgang Hartwig

Holger Zimmermann

Teunis Schuurman

Maarten De Jonge

Thomas Lampe

Peter-Rudolf Seidel

Mario Jeske

Jean M De Vry

Andreas Knorr

Hans-Georg Lerchen

Achim Feurer

Franz-Josef Van Der Staay

Richard T McCarthy

Richard J Fanelli

Jane C Chisholm

Siegfried Goldmann

Rolf Grosser

Jörg Keldenich

Peter Nell

Ulrich Betz

Guy Hewlett

Susanne Nikolic

Nils Griebenow

Tobias Wunberg

Hartmund Wollweber

Johannes Köbberling

Ingo Flamme

Sven Wittrock

Jürgen Reefschläger

Frank Wunder

Peter Fey

Gorden Redlich

Joachim Mittendorf

Kai Thede

Johannes Kaulen

Friederike Stoll

Judith Baumeister

Chantal Fuerstner

Daniela Paulsen

Kai Van Laak

Frank Süssmeier

Maria Köllnberger

David Brueckner

Karl-Heinz Schlemmer

Egbert Wehinger

Alexander Hillisch

Lars Bärfacker

Raimund Kast

Eva-Maria Becker

Hartmut Beck

Marcus Bauser

Gunter Karig

Mark Meininghaus

Otto Behner

Dagmar Karthaus

Gerald Kleymann

Joachim Telser

Metin Akbaba

Martina Klein

Dieter Arlt

Delf Schmidt

Walter Hubsch

Gunter Schmidt

Arnold Paessens

Bernd Riedl

Joerg Keldenich

Ulrich Niewohner

Paul Naab

Claudia Hirth-Dietrich

Ursula Krenz

Frank Süβmeier

Frank Mauler

Niels Svenstrup

Thomas Roelle

Tse-I Lin

Frank Dittmer

Kirsten Börngen

Thomas Krämer

Arno Friedl

Reinhard Jork

Dirk Heimbach

Johannes Koebberling

Christiane Faeste

The invention relates to substituted dihydroquinazolines and to processes for their preparation and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for use as antiviral agents, in particular against cytomegalo viruses.

Substituted dihydroquinazolines

The invention relates to novel polyethylene glycol (PEG) based prodrug of Adrenomedullin, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases, and to the use thereof for producing medicaments for treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders.

Polyethylene glycol based prodrug of adrenomedullin and use thereof

The invention relates to novel tyrosine based linkers that allow the releasable connection of peptides or proteins with other molecular entities, e.g. polyethylene glycol, to processes for their preparation and their use for preparing medicaments for the treatment and/or prophylaxis of diseases.

Tyrosine based linkers for the releasable connection of peptides

The present application relates to novel, cyclically substituted furopyrimidine derivatives, methods for their production, their use for the treatment and/or prophylaxis of diseases and their use for the production of medicinal products for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular diseases.

Cyclically substituted furopyrimidine derivatives and use thereof

The invention relates to substituted arylsulfonamides of formula (I) and methods for their preparation as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses. 

Substituted arylsulfonamides as antiviral agents

The present invention relates to novel substituted pyrazolamides, methods for their preparation, their use for the treatment and/or prophylaxis of diseases, as well as their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of retroviral diseases, in humans and/or animals.

Substituted pyrazolamides and their use

The present application relates to novel, acyclically substituted furopyrimidine derivatives, methods for their production, their use for the treatment and/or prophylaxis of diseases and their use for the production of medicinal products for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular diseases.

Acyclically substituted furopyrimidine derivatives and use thereof

The invention relates to substituted quinolones and to methods for their preparation as well as to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses.

Substituted quinolones III

The invention relates to dihydroquinazolines and methods for the production thereof, the use thereof in the treatment and/or prophylaxis of diseases, in addition to the use thereof in the production of medicaments in the treatment and/or prophylaxis of diseases, especially for use as anti-viral agents, especially against cytomegalo viruses.

2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses

The invention relates to substituted quinolones and to processes for their preparation as well as to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses.

Substituted quinolones

The invention relates to substituted quinolones of formula (I) and to methods for their preparation as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, in particular against cytomegaloviruses. 

Substituted quinolones II

Growing community of inventors

Wuppertal, Germany

Rudolf Schohe-Loop